Foresite Capital’s Fundraising

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Foresite Capital on the deal.

Foresite Capital announced the formation of the fund’s fifth fund, which is comprised of two separate investment vehicles, Foresite Capital Fund V and Foresite Capital Opportunity Fund V. The firm secured $969 million in capital commitments and will focus on healthcare and life sciences.  

Foresite’s affiliated incubator, Foresite Labs, combined with Foresite’s expertise in public market investing, uniquely positions Foresite to support companies from inception through an IPO and beyond.

Foresite Capital Management, LLC provides capital solutions. The Company invests in the areas of healthcare, therapeutics, medical devices, diagnostics, and services.

The Gunderson deal team was led by Christi Niehans Frentz (Picture) and included Christopher Partin and Sally Yi.

 

Involved fees earner: Christi Niehans – Gunderson Dettmer; Christopher Partin – Gunderson Dettmer; Sally Yi – Gunderson Dettmer;

Law Firms: Gunderson Dettmer;

Clients: Foresite Capital ;

Author: Martina Bellini